FOXO1 and Hyperglycemia: Our data demonstrates abnormal expression of gluconeogenesis-related enzymes, PGC1α and decreased phosphorylated levels of FoxO1 in the liver, suggesting defects in the hepatic insulin-AKT-FoxO1 signaling pathway resulting in enhanced gluconeogenesis and systemic hyperglycemia in response to PM2.5 inhalation.